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OBJECTIVE — Any combination of metabolic abnormalities may constitute the metabolic
syndrome (MetS), conferring coronary artery disease (CAD) risk, but the independent effect of
different combinations on CAD onset remains unknown.
RESEARCH DESIGN AND METHODS — Healthy adult siblings (n  987) of prema-
ture CAD (60 years) case subjects were followed for 9.8  3.8 years. Baseline MetS variables
(insulin sensitivity index, waist circumference, systolic blood pressure, HDL cholesterol, and
triglycerides) were recombined into ﬁve principal components (PC1–5), and risk factor–
adjusted proportional hazards for CAD onset of median-dichotomized PCs were estimated.
RESULTS — The signiﬁcant hazard ratios were as follows: for PC1 (all abnormalities except
blood pressure) 1.66 (P  0.036), PC2 (high blood pressure levels, high HDL cholesterol) 1.71
(P  0.016), and PC4 (low HDL cholesterol, high insulin sensitivity, low triglycerides) 2.0 (P 
0.001). Traditionally deﬁned MetS had a hazard ratio of 1.32 (P  0.18).
CONCLUSIONS — Independent MetS variants identiﬁed by PC analysis may explain met-
abolic mechanisms that increase CAD risk better than the presence of traditional MetS.
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A
common approach to examining
the metabolic syndrome (MetS)
uses a simple count without taking
into account the correlation structure of
dichotomous metabolic abnormalities in-
cluding increased blood pressure, high
triglyceridelevels,lowHDLcholesterollev-
els, abdominal obesity, and impaired glu-
cose control (1). The goal of this study was
to deﬁne the structure of independent pat-
terns of metabolic syndrome variables and
determinetheirabilitytopredictnew-onset
coronary artery disease (CAD).
RESEARCH DESIGN AND
METHODS
Population and follow-up
The study was approved by the Johns
HopkinsInstitutionalReviewBoard.Sub-
jects gave informed consent. The sample
included 987 apparently healthy white
and African American siblings (60
years) of index case subjects (each identi-
fying 1 of 522 families) admitted to hos-
pitals with CAD events at 60 years of
age. New-onset CAD events were fol-
lowedupoverameanperiodof9.83.8
years (mean  SD). Details regarding in-
dexcasesubjectsandfollow-upadjudica-
tion are included in the online appendix,
available at http://care.diabetesjournals.
org/cgi/content/full/dc09-2211/DC1.
Screening and metabolic measures
Detailed measurement techniques for
blood pressure, fasting lipid proﬁle, glu-
cose, and insulin are included in the on-
line appendix. In addition to variables
used by the National Cholesterol Educa-
tion Program (NCEP)–Adult Treatment
Panel (ATP)-III (1)—namely systolic
blood pressure, fasting triglycerides and
HDL cholesterol, and waist circumfer-
ence—we included the Quantitative
Check Index of Insulin Sensitivity
{QUICKI  1/[log(fasting insulin)  log-
(fasting glucose)]} (2) because other deﬁ-
nitions of MetS (3,4) include insulin
resistance.
Statistical analysis
Principalcomponent(PC)calculationad-
justing for age, sex, and family structure
andtheirinterpretationaredetailedinthe
online appendix. PC variants were di-
chotomizedatthemedianscore.Coxpro-
portional hazard models were evaluated
with age of CAD onset as the underlying
time scale, adjusting for sex, race, current
smoking, LDL cholesterol, and blood
pressure medication use. A regression
model for NCEP–ATP-III MetS (as de-
ﬁned by Grundy et al. [1]) was also
estimated.
RESULTS
Sample characteristics
The sample of 987 individuals consisted
of 40% male and 58% African American
and had an age range of 27–60 years. Ta-
ble A1 (available in the online appendix)
shows baseline sample characteristics by
new-onset CAD event status during fol-
low-up (106 events in 99 families).
Principal components analysis of
metabolic variables
Table A2 shows the proportion of vari-
ance in the metabolic variables explained
by the ﬁve PC-derived components and
their eigenvector weights. Nearly half
(49%) of the variance is explained by the
ﬁrst principal component (PC1), which
represents quantitatively greater waist
and triglycerides and lower HDL choles-
terol and insulin sensitivity when positive
and the converse when negative. PC1 val-
ues strongly correlate with the prevalence
of NCEP-deﬁned MetS (highest PC1
quartile: 92%, lowest PC1 quartile: 2%,
NCEP-MetS prevalence, trend P 
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represent the following: PC2, high sys-
tolic blood pressure and high HDL cho-
lesterol; PC3, low waist circumference
and high QUICKI with high systolic
blood pressure and triglycerides; PC4,
high QUICKI and low triglycerides but
with low HDL cholesterol; PC5, high
QUICKI, large waist circumference, and
high triglycerides; negative scores repre-
sent opposite patterns.
Association of MetS principal
components with new-onset CAD
Unadjusted incidence curves by PC score
are shown in Fig. A1 in the online appen-
dix. The age, sex, race, and risk factor–
adjusted relative hazards of the PCs
(dichotomizedatthemedian)andNCEP–
ATP-III MetS are shown in Fig. 1. PC1,
PC2, and PC4 are independently associ-
ated with a signiﬁcant hazard ratio of
new-onset CAD. The hazard ratio associ-
atedwiththehigherlevelofPC1isgreater
than that associated with the NCEP-
deﬁned MetS (estimated in a separate
model), which is not statistically signiﬁ-
cant in this sample.
CONCLUSIONS — This is the ﬁrst
study demonstrating the association of
PC-derived independent metabolic syn-
drome variants with new-onset CAD
events in an initially healthy population.
PC4 representing lower HDL cholesterol
levels in the absence of insulin insensitiv-
ity and other metabolic variables doubles
the risk of CAD. PC1, although it resem-
bles the ATP-III–deﬁned MetS (1), pro-
ducesamuchmorepotentestimateofrisk
for incident CAD than the ATP-III–
deﬁned MetS, because it weights the met-
abolic abnormalities better than a simple
count.Furthermore,thelinearPCcombi-
nation threshold at the mean may be
more efﬁcient than the predeﬁned tra-
ditional thresholds. PC2 representing
mostly higher systolic blood pressure in
an otherwise healthy metabolic context
causes a 70% increase in the risk of in-
cidentCAD.Inaddition,thePCanalysis
also shows that higher triglyceride lev-
els as found in PC3 and PC5 are not
associated with incident CAD unless
they occur in the presence of multiple
other metabolic risk factors, as in PC1.
Importantly, these CAD-related PC
variants are not captured in the NCEP–
ATP-III MetS.
Although PC4 represents only 9% of
the metabolic variation, it is signiﬁcantly
associated with incident CAD indepen-
dently of the other variables and PC vari-
ables. This component (insulin
sensitivity combined with lower HDL
cholesterol and lower triglycerides)
would be ignored by previous PC anal-
yses (5,6) where dimensionality reduc-
tion, rather than deﬁning CAD risk, was
the primary intent.
Systemic manifestations of insulin re-
sistance underpin for the pattern of cor-
relation represented by our PC1 (7).
Superimposed on PC1, HDL cholesterol
levels are associated with differential risk
based on the pattern of other metabolic
variables. We may speculate that lipid
dysmetabolism including more athero-
genic subfractions of HDL may manifest
as PC2 (8). However, unifying biological
themes may underlie the other PC vari-
ables and remain to be discovered.
Strengths and limitations
The prospective design allowing analysis
of the age of CAD onset in an easily iden-
tiﬁable white and African American high-
risk cohort is a signiﬁcant strength.
Further replication in the general popula-
tion would make the study results more
widelyapplicable.AlimitationofPCanal-
ysis is that the choice of variables can be
somewhat arbitrary. However, variables
we chose include important features of
most current MetS deﬁnitions.
Inconclusion,wehaveshownthatin-
dependent of the well-known MetS pat-
tern, and superimposed upon it, there is
signiﬁcant risk of CAD conferred by two
other novel metabolic patterns: high
bloodpressurewithhighHDLcholesterol
andhighinsulinsensitivitywithlowHDL
cholesterol and low triglycerides. Further
basic and clinical research is needed to
elucidate the biological underpinnings of
our results.
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